Geode Capital Management’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6K Buy
17,148
+2,789
+19% +$2.89K ﹤0.01% 4418
2026
Q1
$20.6K Buy
14,359
+10,877
+312% +$25.2K ﹤0.01% 4445
2025
Q4
$9.62K Buy
+3,482
New +$20.9K ﹤0.01% 4436
2025
Q1
Sell
-2,205
Closed -$56.8K 4504
2024
Q4
$56.8K Hold
2,205
﹤0.01% 4220
2024
Q3
$88.9K Buy
2,205
+566
+35% +$28.5K ﹤0.01% 4136
2024
Q2
$60.3K Buy
1,639
+158
+11% +$7.41K ﹤0.01% 4242
2024
Q1
$109K Hold
1,481
﹤0.01% 4139
2023
Q4
$131K Hold
1,481
﹤0.01% 4091
2023
Q3
$140K Buy
1,481
+86
+6% +$11.1K ﹤0.01% 4127
2023
Q2
$250K Hold
1,395
﹤0.01% 3941
2023
Q1
$366K Hold
1,395
﹤0.01% 3775
2022
Q4
$214K Buy
1,395
+54
+4% +$9.47K ﹤0.01% 4061
2022
Q3
$293K Hold
1,341
﹤0.01% 4004
2022
Q2
$641K Buy
1,341
+32
+2% +$11.6K ﹤0.01% 3627
2022
Q1
$594K Buy
1,309
+1,232
+1,600% +$628K ﹤0.01% 3856
2021
Q4
$14K Buy
+77
New +$20.8K ﹤0.01% 4959

Other funds holding EDVA

Geode Capital Management's EDVA Position: Q2 2026 in Review

Geode Capital Management increased its Endovia Health Sciences, Inc. (EDVA) stake by 19% in Q2 2026, buying an estimated $2.89K and bringing the position to 17,148 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4418.

Geode Capital Management first reported a position in EDVA in Q4 2021 and has held it in 16 quarters since. The position peaked at $641K in Q2 2022. 18 funds tracked by Wall St. Rank hold EDVA as of Q2 2026.

  • Geode Capital Management held 17,148 shares of Endovia Health Sciences, Inc. worth $10.6K as of Q2 2026.
  • Geode Capital Management bought 2,789 Endovia Health Sciences, Inc. shares in Q2 2026, an estimated $2.89K.
  • Endovia Health Sciences, Inc. made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4418 holding.
  • Geode Capital Management first reported a position in Endovia Health Sciences, Inc. in Q4 2021 and has held it in 16 quarters since.
  • Geode Capital Management's Endovia Health Sciences, Inc. position peaked at $641K in Q2 2022.
  • 18 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.